2024-06-012025-05-312025-05-31false07206448Medex (NW) Limited2025-10-30falseiso4217:GBPxbrli:pure072064482024-05-31072064482025-05-31072064482024-06-012025-05-31072064482023-05-31072064482024-05-31072064482023-06-012024-05-3107206448bus:SmallEntities2024-06-012025-05-3107206448bus:AuditExempt-NoAccountantsReport2024-06-012025-05-3107206448bus:FullAccounts2024-06-012025-05-3107206448bus:PrivateLimitedCompanyLtd2024-06-012025-05-3107206448core:WithinOneYear2025-05-3107206448core:AfterOneYear2025-05-3107206448core:WithinOneYear2024-05-3107206448core:AfterOneYear2024-05-3107206448core:ShareCapital2025-05-3107206448core:SharePremium2025-05-3107206448core:RevaluationReserve2025-05-3107206448core:OtherReservesSubtotal2025-05-3107206448core:RetainedEarningsAccumulatedLosses2025-05-3107206448core:ShareCapital2024-05-3107206448core:SharePremium2024-05-3107206448core:RevaluationReserve2024-05-3107206448core:OtherReservesSubtotal2024-05-3107206448core:RetainedEarningsAccumulatedLosses2024-05-3107206448core:LandBuildings2025-05-3107206448core:PlantMachinery2025-05-3107206448core:Vehicles2025-05-3107206448core:FurnitureFittings2025-05-3107206448core:OfficeEquipment2025-05-3107206448core:NetGoodwill2025-05-3107206448core:IntangibleAssetsOtherThanGoodwill2025-05-3107206448core:ListedExchangeTraded2025-05-3107206448core:UnlistedNon-exchangeTraded2025-05-3107206448core:LandBuildings2024-05-3107206448core:PlantMachinery2024-05-3107206448core:Vehicles2024-05-3107206448core:FurnitureFittings2024-05-3107206448core:OfficeEquipment2024-05-3107206448core:NetGoodwill2024-05-3107206448core:IntangibleAssetsOtherThanGoodwill2024-05-3107206448core:ListedExchangeTraded2024-05-3107206448core:UnlistedNon-exchangeTraded2024-05-3107206448core:LandBuildings2024-06-012025-05-3107206448core:PlantMachinery2024-06-012025-05-3107206448core:Vehicles2024-06-012025-05-3107206448core:FurnitureFittings2024-06-012025-05-3107206448core:OfficeEquipment2024-06-012025-05-3107206448core:NetGoodwill2024-06-012025-05-3107206448core:IntangibleAssetsOtherThanGoodwill2024-06-012025-05-3107206448core:ListedExchangeTraded2024-06-012025-05-3107206448core:UnlistedNon-exchangeTraded2024-06-012025-05-3107206448core:MoreThanFiveYears2024-06-012025-05-3107206448core:Non-currentFinancialInstruments2025-05-3107206448core:Non-currentFinancialInstruments2024-05-3107206448dpl:CostSales2024-06-012025-05-3107206448dpl:DistributionCosts2024-06-012025-05-3107206448core:LandBuildings2024-06-012025-05-3107206448core:PlantMachinery2024-06-012025-05-3107206448core:Vehicles2024-06-012025-05-3107206448core:FurnitureFittings2024-06-012025-05-3107206448core:OfficeEquipment2024-06-012025-05-3107206448dpl:AdministrativeExpenses2024-06-012025-05-3107206448core:NetGoodwill2024-06-012025-05-3107206448core:IntangibleAssetsOtherThanGoodwill2024-06-012025-05-3107206448dpl:GroupUndertakings2024-06-012025-05-3107206448dpl:ParticipatingInterests2024-06-012025-05-3107206448dpl:GroupUndertakingscore:ListedExchangeTraded2024-06-012025-05-3107206448core:ListedExchangeTraded2024-06-012025-05-3107206448dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2024-06-012025-05-3107206448core:UnlistedNon-exchangeTraded2024-06-012025-05-3107206448dpl:CostSales2023-06-012024-05-3107206448dpl:DistributionCosts2023-06-012024-05-3107206448core:LandBuildings2023-06-012024-05-3107206448core:PlantMachinery2023-06-012024-05-3107206448core:Vehicles2023-06-012024-05-3107206448core:FurnitureFittings2023-06-012024-05-3107206448core:OfficeEquipment2023-06-012024-05-3107206448dpl:AdministrativeExpenses2023-06-012024-05-3107206448core:NetGoodwill2023-06-012024-05-3107206448core:IntangibleAssetsOtherThanGoodwill2023-06-012024-05-3107206448dpl:GroupUndertakings2023-06-012024-05-3107206448dpl:ParticipatingInterests2023-06-012024-05-3107206448dpl:GroupUndertakingscore:ListedExchangeTraded2023-06-012024-05-3107206448core:ListedExchangeTraded2023-06-012024-05-3107206448dpl:GroupUndertakingscore:UnlistedNon-exchangeTraded2023-06-012024-05-3107206448core:UnlistedNon-exchangeTraded2023-06-012024-05-3107206448core:NetGoodwill2025-05-3107206448core:IntangibleAssetsOtherThanGoodwill2025-05-3107206448core:LandBuildings2025-05-3107206448core:PlantMachinery2025-05-3107206448core:Vehicles2025-05-3107206448core:FurnitureFittings2025-05-3107206448core:OfficeEquipment2025-05-3107206448core:AfterOneYear2025-05-3107206448core:WithinOneYear2025-05-3107206448core:ListedExchangeTraded2025-05-3107206448core:UnlistedNon-exchangeTraded2025-05-3107206448core:ShareCapital2025-05-3107206448core:SharePremium2025-05-3107206448core:RevaluationReserve2025-05-3107206448core:OtherReservesSubtotal2025-05-3107206448core:RetainedEarningsAccumulatedLosses2025-05-3107206448core:NetGoodwill2024-05-3107206448core:IntangibleAssetsOtherThanGoodwill2024-05-3107206448core:LandBuildings2024-05-3107206448core:PlantMachinery2024-05-3107206448core:Vehicles2024-05-3107206448core:FurnitureFittings2024-05-3107206448core:OfficeEquipment2024-05-3107206448core:AfterOneYear2024-05-3107206448core:WithinOneYear2024-05-3107206448core:ListedExchangeTraded2024-05-3107206448core:UnlistedNon-exchangeTraded2024-05-3107206448core:ShareCapital2024-05-3107206448core:SharePremium2024-05-3107206448core:RevaluationReserve2024-05-3107206448core:OtherReservesSubtotal2024-05-3107206448core:RetainedEarningsAccumulatedLosses2024-05-3107206448core:NetGoodwill2023-05-3107206448core:IntangibleAssetsOtherThanGoodwill2023-05-3107206448core:LandBuildings2023-05-3107206448core:PlantMachinery2023-05-3107206448core:Vehicles2023-05-3107206448core:FurnitureFittings2023-05-3107206448core:OfficeEquipment2023-05-3107206448core:AfterOneYear2023-05-3107206448core:WithinOneYear2023-05-3107206448core:ListedExchangeTraded2023-05-3107206448core:UnlistedNon-exchangeTraded2023-05-3107206448core:ShareCapital2023-05-3107206448core:SharePremium2023-05-3107206448core:RevaluationReserve2023-05-3107206448core:OtherReservesSubtotal2023-05-3107206448core:RetainedEarningsAccumulatedLosses2023-05-3107206448core:AfterOneYear2024-06-012025-05-3107206448core:WithinOneYear2024-06-012025-05-3107206448core:Non-currentFinancialInstrumentscore:CostValuation2024-06-012025-05-3107206448core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-06-012025-05-3107206448core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-06-012025-05-3107206448core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-06-012025-05-3107206448core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-06-012025-05-3107206448core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-06-012025-05-3107206448core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-06-012025-05-3107206448core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-06-012025-05-3107206448core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-06-012025-05-3107206448core:Non-currentFinancialInstrumentscore:CostValuation2025-05-3107206448core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2025-05-3107206448core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2025-05-3107206448core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2025-05-3107206448core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2025-05-3107206448core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2025-05-3107206448core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2025-05-3107206448core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2025-05-3107206448core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2025-05-3107206448core:Non-currentFinancialInstrumentscore:CostValuation2024-05-3107206448core:Non-currentFinancialInstrumentscore:AdditionsToInvestments2024-05-3107206448core:Non-currentFinancialInstrumentscore:RevaluationsIncreaseDecreaseInInvestments2024-05-3107206448core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInInvestments2024-05-3107206448core:Non-currentFinancialInstrumentscore:ProvidedReleasedInPeriodProvisionsForImpairmentInvestments2024-05-3107206448core:Non-currentFinancialInstrumentscore:ImpairmentLossReversalProvisionsForImpairmentInvestments2024-05-3107206448core:Non-currentFinancialInstrumentscore:AcquisitionsIncreaseInProvisionsForImpairmentInvestments2024-05-3107206448core:Non-currentFinancialInstrumentscore:DisposalsDecreaseInProvisionsForImpairmentInvestments2024-05-3107206448core:Non-currentFinancialInstrumentscore:OtherIncreaseDecreaseInProvisionsForImpairmentInvestments2024-05-3107206448bus:Director12024-06-012025-05-3107206448bus:Director22024-06-012025-05-31

Medex (NW) Limited

Registered Number
07206448
(England and Wales)

Unaudited Financial Statements for the Year ended
31 May 2025

Medex (NW) Limited
Company Information
for the year from 1 June 2024 to 31 May 2025

Directors

Clare Smith
Robert Smith

Registered Address

6 Broadoaks Road
Sale
M33 7SR

Registered Number

07206448 (England and Wales)
Medex (NW) Limited
Balance Sheet as at
31 May 2025

Notes

2025

2024

£

£

£

£

Fixed assets
Tangible assets39,2047,860
9,2047,860
Current assets
Debtors465,82556,907
Cash at bank and on hand104,97868,302
170,803125,209
Creditors amounts falling due within one year5(55,498)(28,574)
Net current assets (liabilities)115,30596,635
Total assets less current liabilities124,509104,495
Provisions for liabilities6(2,301)(1,493)
Net assets122,208103,002
Capital and reserves
Called up share capital100100
Profit and loss account122,108102,902
Shareholders' funds122,208103,002
The financial statements were approved and authorised for issue by the Board of Directors on 30 October 2025, and are signed on its behalf by:
Clare Smith
Director
Robert Smith
Director

Registered Company No. 07206448
Medex (NW) Limited
Notes to the Financial Statements
for the year ended 31 May 2025

1.Accounting policies
Statutory information
The company is a private company limited by shares and registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.
Statement of compliance
The financial statements have been prepared in compliance with FRS 102 Section 1A as it applies to the financial statements for the period and there were no material departures from the reporting standard.
Revenue from rendering of services
Revenue from the rendering of services is recognised by reference to the stage of completion of the contract. The stage of completion of a contract is measured by comparing the costs incurred for work performed to date to the total estimated contract costs. Turnover is only recognised to the extent of recoverable expenses when the outcome of a contract cannot be estimated reliably.
Employee benefits
Contributions to defined contribution plans are expensed in the period to which they relate.
Deferred tax
Deferred tax is recognised in respect of all timing differences between the recognition of income and expenses in the financial statements and their inclusion in tax assessments. Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference, except for revalued land and investment property where the tax rate that applies to the sale of the asset is used. Current and deferred tax assets and liabilities are not discounted.
Tangible fixed assets and depreciation
Tangible fixed assets are stated at cost or valuation less depreciation. Depreciation is provided on all tangible fixed assets as follows:

Reducing balance (%)
Office Equipment25
Trade and other debtors
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
2.Average number of employees

20252024
Average number of employees during the year22
3.Tangible fixed assets

Office Equipment

Total

££
Cost or valuation
At 01 June 2429,30029,300
Additions3,9883,988
At 31 May 2533,28833,288
Depreciation and impairment
At 01 June 2421,44021,440
Charge for year2,6442,644
At 31 May 2524,08424,084
Net book value
At 31 May 259,2049,204
At 31 May 247,8607,860
4.Debtors: amounts due within one year

2025

2024

££
Trade debtors / trade receivables65,40656,907
Other debtors419-
Total65,82556,907
Short term debtors are measured at transaction price (which is usually the invoice price), less any impairment losses for bad and doubtful debts. Loans and other financial assets are initially recognised at transaction price including any transaction costs and subsequently measured at amortised cost determined using the effective interest method, less any impairment losses for bad and doubtful debts.
5.Creditors: amounts due within one year

2025

2024

££
Taxation and social security51,17525,200
Other creditors1,462749
Accrued liabilities and deferred income2,8612,625
Total55,49828,574
Short term creditors are measured at transaction price (which is usually the invoice price). Loans and other financial liabilities are initially recognised at transaction price net of any transaction costs and subsequently measured at amortised cost determined using the effective interest method.
6.Provisions for liabilities

2025

2024

££
Net deferred tax liability (asset)2,3011,493
Total2,3011,493